nodes	percent_of_prediction	percent_of_DWPC	metapath
Suramin—PLA2G2A—synovial fluid—osteoarthritis	0.136	0.268	CbGeAlD
Suramin—F2—knee—osteoarthritis	0.0923	0.183	CbGeAlD
Suramin—F2—vertebral column—osteoarthritis	0.0526	0.104	CbGeAlD
Suramin—F2—leg—osteoarthritis	0.0506	0.1	CbGeAlD
Suramin—F2—forelimb—osteoarthritis	0.0503	0.0995	CbGeAlD
Suramin—F2—hindlimb—osteoarthritis	0.0452	0.0895	CbGeAlD
Suramin—SIRT5—tendon—osteoarthritis	0.0174	0.0344	CbGeAlD
Suramin—P2RX4—tendon—osteoarthritis	0.0164	0.0325	CbGeAlD
Suramin—SIRT1—tendon—osteoarthritis	0.0144	0.0285	CbGeAlD
Suramin—RYR1—tendon—osteoarthritis	0.0133	0.0263	CbGeAlD
Suramin—PLA2G2A—tendon—osteoarthritis	0.0101	0.02	CbGeAlD
Suramin—RYR1—Calcium Regulation in the Cardiac Cell—CAMK2B—osteoarthritis	0.00759	0.0153	CbGpPWpGaD
Suramin—ARSA—Post-translational protein modification—ADAMTS5—osteoarthritis	0.00755	0.0153	CbGpPWpGaD
Suramin—ARSA—Post-translational protein modification—ADAMTS3—osteoarthritis	0.00755	0.0153	CbGpPWpGaD
Suramin—RYR1—Myometrial Relaxation and Contraction Pathways—CAMK2B—osteoarthritis	0.00735	0.0149	CbGpPWpGaD
Suramin—PLA2G4A—tendon—osteoarthritis	0.00701	0.0139	CbGeAlD
Suramin—ARSA—Post-translational protein modification—ADAMTS4—osteoarthritis	0.00642	0.013	CbGpPWpGaD
Suramin—PLA2G2A—Eicosanoid Synthesis—PTGS2—osteoarthritis	0.00641	0.013	CbGpPWpGaD
Suramin—P2RY2—GPCR ligand binding—IHH—osteoarthritis	0.00629	0.0127	CbGpPWpGaD
Suramin—FSHR—GPCR ligand binding—IHH—osteoarthritis	0.00607	0.0123	CbGpPWpGaD
Suramin—PLA2G2A—Spinal Cord Injury—COL2A1—osteoarthritis	0.00595	0.012	CbGpPWpGaD
Suramin—F2—Regulation of IGF Activity by IGFBP—MMP1—osteoarthritis	0.00555	0.0112	CbGpPWpGaD
Suramin—SIRT1—Androgen receptor signaling pathway—SMAD3—osteoarthritis	0.00534	0.0108	CbGpPWpGaD
Suramin—F2—Regulation of IGF Activity by IGFBP—IGF1—osteoarthritis	0.00443	0.00896	CbGpPWpGaD
Suramin—PLA2G2A—Glypican 1 network—TGFB1—osteoarthritis	0.00435	0.00879	CbGpPWpGaD
Suramin—F2—Regulation of IGF Activity by IGFBP—MMP2—osteoarthritis	0.00429	0.00867	CbGpPWpGaD
Suramin—SIRT1—Cellular responses to stress—CAMK2B—osteoarthritis	0.0042	0.00848	CbGpPWpGaD
Suramin—ARSA—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	0.00403	0.00815	CbGpPWpGaD
Suramin—PLA2G2A—Cardiac Hypertrophic Response—IGF1—osteoarthritis	0.00398	0.00805	CbGpPWpGaD
Suramin—ARSA—Metabolism of proteins—ADAMTS13—osteoarthritis	0.00381	0.0077	CbGpPWpGaD
Suramin—PLA2G4A—AGE/RAGE pathway—MMP13—osteoarthritis	0.00379	0.00766	CbGpPWpGaD
Suramin—P2RY2—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—osteoarthritis	0.00378	0.00763	CbGpPWpGaD
Suramin—F2—Syndecan-4-mediated signaling events—FN1—osteoarthritis	0.00361	0.0073	CbGpPWpGaD
Suramin—ARSA—Metabolism of proteins—ADAMTS5—osteoarthritis	0.00358	0.00724	CbGpPWpGaD
Suramin—ARSA—Metabolism of proteins—ADAMTS3—osteoarthritis	0.00358	0.00724	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—MCF2L—osteoarthritis	0.00355	0.00718	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—MCF2L—osteoarthritis	0.00343	0.00694	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—IHH—osteoarthritis	0.00323	0.00652	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—MCF2L—osteoarthritis	0.00323	0.00652	CbGpPWpGaD
Suramin—F2—Platelet Aggregation (Plug Formation)—FN1—osteoarthritis	0.00322	0.0065	CbGpPWpGaD
Suramin—PLA2G2A—Spinal Cord Injury—IL1A—osteoarthritis	0.0032	0.00647	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—MCF2L—osteoarthritis	0.00312	0.0063	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—IHH—osteoarthritis	0.00312	0.0063	CbGpPWpGaD
Suramin—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—ESR1—osteoarthritis	0.00311	0.00629	CbGpPWpGaD
Suramin—SIRT1—Integrated Breast Cancer Pathway—MMP1—osteoarthritis	0.00309	0.00625	CbGpPWpGaD
Suramin—F2—IL1 and megakaryotyces in obesity—IL1B—osteoarthritis	0.00307	0.00621	CbGpPWpGaD
Suramin—ARSA—Metabolism of proteins—ADAMTS4—osteoarthritis	0.00304	0.00615	CbGpPWpGaD
Suramin—F2—IL1 and megakaryotyces in obesity—MMP9—osteoarthritis	0.0029	0.00586	CbGpPWpGaD
Suramin—SIRT1—Integrated Breast Cancer Pathway—ESR1—osteoarthritis	0.00286	0.00577	CbGpPWpGaD
Suramin—PLA2G2A—MicroRNAs in cardiomyocyte hypertrophy—IGF1—osteoarthritis	0.00284	0.00574	CbGpPWpGaD
Suramin—F2—Vitamin B12 Metabolism—CRP—osteoarthritis	0.0027	0.00545	CbGpPWpGaD
Suramin—F2—Post-translational protein modification—ADAMTS13—osteoarthritis	0.00266	0.00538	CbGpPWpGaD
Suramin—PLA2G2A—Spinal Cord Injury—LEP—osteoarthritis	0.00262	0.00529	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	0.0026	0.00525	CbGpPWpGaD
Suramin—SIRT1—Signaling events mediated by HDAC Class I—TNF—osteoarthritis	0.00256	0.00517	CbGpPWpGaD
Suramin—F2—Angiopoietin receptor Tie2-mediated signaling—FN1—osteoarthritis	0.00253	0.00511	CbGpPWpGaD
Suramin—PLA2G4A—Prostaglandin Synthesis and Regulation—PTGS2—osteoarthritis	0.00253	0.00511	CbGpPWpGaD
Suramin—F2—Post-translational protein modification—ADAMTS5—osteoarthritis	0.0025	0.00506	CbGpPWpGaD
Suramin—F2—Post-translational protein modification—ADAMTS3—osteoarthritis	0.0025	0.00506	CbGpPWpGaD
Suramin—PLA2G2A—Cardiac Hypertrophic Response—TGFB1—osteoarthritis	0.00239	0.00483	CbGpPWpGaD
Suramin—SIRT1—Circadian rythm related genes—LEP—osteoarthritis	0.00238	0.00481	CbGpPWpGaD
Suramin—SIRT1—Integrated Pancreatic Cancer Pathway—ESR1—osteoarthritis	0.00237	0.00478	CbGpPWpGaD
Suramin—SIRT1—Cellular responses to stress—IL1A—osteoarthritis	0.00234	0.00473	CbGpPWpGaD
Suramin—F2—Syndecan-4-mediated signaling events—MMP9—osteoarthritis	0.0023	0.00465	CbGpPWpGaD
Suramin—PLA2G4A—AGE/RAGE pathway—SMAD3—osteoarthritis	0.0023	0.00464	CbGpPWpGaD
Suramin—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—PTGS2—osteoarthritis	0.00223	0.00452	CbGpPWpGaD
Suramin—PLA2G2A—Cardiac Hypertrophic Response—TNF—osteoarthritis	0.00223	0.00451	CbGpPWpGaD
Suramin—ARSA—Metabolism—FMOD—osteoarthritis	0.0022	0.00445	CbGpPWpGaD
Suramin—F2—Folate Metabolism—CRP—osteoarthritis	0.00219	0.00443	CbGpPWpGaD
Suramin—F2—Angiopoietin receptor Tie2-mediated signaling—MMP2—osteoarthritis	0.00214	0.00433	CbGpPWpGaD
Suramin—RYR1—Myometrial Relaxation and Contraction Pathways—IL1B—osteoarthritis	0.00214	0.00432	CbGpPWpGaD
Suramin—F2—Post-translational protein modification—ADAMTS4—osteoarthritis	0.00213	0.0043	CbGpPWpGaD
Suramin—PLA2G4A—Endothelins—MMP1—osteoarthritis	0.00211	0.00426	CbGpPWpGaD
Suramin—SIRT1—Integrated Pancreatic Cancer Pathway—IGF1—osteoarthritis	0.00205	0.00414	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—MCF2L—osteoarthritis	0.00191	0.00385	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—IHH—osteoarthritis	0.00191	0.00385	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—MCF2L—osteoarthritis	0.00184	0.00372	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—IHH—osteoarthritis	0.00184	0.00372	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—IHH—osteoarthritis	0.0018	0.00363	CbGpPWpGaD
Suramin—ARSA—Metabolism—PTGES—osteoarthritis	0.0018	0.00363	CbGpPWpGaD
Suramin—PLA2G2A—Spinal Cord Injury—PTGS2—osteoarthritis	0.00179	0.00363	CbGpPWpGaD
Suramin—F2—Selenium Micronutrient Network—CRP—osteoarthritis	0.00174	0.00352	CbGpPWpGaD
Suramin—ARSA—Metabolism of proteins—HSPA5—osteoarthritis	0.00174	0.00352	CbGpPWpGaD
Suramin—PLA2G2A—Spinal Cord Injury—CXCL8—osteoarthritis	0.00174	0.00352	CbGpPWpGaD
Suramin—PLA2G2A—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—osteoarthritis	0.0017	0.00344	CbGpPWpGaD
Suramin—SIRT1—Integrated Pancreatic Cancer Pathway—PTGS2—osteoarthritis	0.0017	0.00343	CbGpPWpGaD
Suramin—F2—Vitamin B12 Metabolism—IL1B—osteoarthritis	0.00168	0.0034	CbGpPWpGaD
Suramin—PLA2G4A—Arachidonic acid metabolism—PTGS2—osteoarthritis	0.00168	0.0034	CbGpPWpGaD
Suramin—PLA2G2A—Spinal Cord Injury—IL1B—osteoarthritis	0.00167	0.00337	CbGpPWpGaD
Suramin—F2—Cell surface interactions at the vascular wall—MMP1—osteoarthritis	0.0016	0.00324	CbGpPWpGaD
Suramin—PLA2G2A—MicroRNAs in cardiomyocyte hypertrophy—TNF—osteoarthritis	0.00159	0.00321	CbGpPWpGaD
Suramin—PLA2G2A—Spinal Cord Injury—MMP9—osteoarthritis	0.00157	0.00318	CbGpPWpGaD
Suramin—PLA2G4A—AGE/RAGE pathway—MMP2—osteoarthritis	0.00157	0.00317	CbGpPWpGaD
Suramin—F2—Cell surface interactions at the vascular wall—FN1—osteoarthritis	0.00146	0.00296	CbGpPWpGaD
Suramin—P2RY2—Class A/1 (Rhodopsin-like receptors)—CXCL8—osteoarthritis	0.00144	0.0029	CbGpPWpGaD
Suramin—F2—Platelet activation, signaling and aggregation—HSPA5—osteoarthritis	0.00142	0.00288	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—FMOD—osteoarthritis	0.00142	0.00287	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—COL9A2—osteoarthritis	0.0014	0.00283	CbGpPWpGaD
Suramin—FSHR—Class A/1 (Rhodopsin-like receptors)—CXCL8—osteoarthritis	0.00139	0.00281	CbGpPWpGaD
Suramin—F2—Folate Metabolism—IL1B—osteoarthritis	0.00137	0.00277	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—COL9A1—osteoarthritis	0.00136	0.00275	CbGpPWpGaD
Suramin—F2—Platelet activation, signaling and aggregation—TIMP1—osteoarthritis	0.00136	0.00274	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—COL9A2—osteoarthritis	0.00135	0.00273	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—COL9A1—osteoarthritis	0.00131	0.00265	CbGpPWpGaD
Suramin—PLA2G4A—Platelet activation, signaling and aggregation—HSPA5—osteoarthritis	0.0013	0.00263	CbGpPWpGaD
Suramin—PLA2G2A—Spinal Cord Injury—TGFB1—osteoarthritis	0.0013	0.00262	CbGpPWpGaD
Suramin—SIRT1—Cellular responses to stress—CXCL8—osteoarthritis	0.00127	0.00257	CbGpPWpGaD
Suramin—ARSA—Metabolism—GSTO1—osteoarthritis	0.00126	0.00256	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—ADAMTS13—osteoarthritis	0.00126	0.00256	CbGpPWpGaD
Suramin—RYR1—Myometrial Relaxation and Contraction Pathways—IL6—osteoarthritis	0.00125	0.00253	CbGpPWpGaD
Suramin—PLA2G4A—Platelet activation, signaling and aggregation—TIMP1—osteoarthritis	0.00124	0.00251	CbGpPWpGaD
Suramin—F2—Angiopoietin receptor Tie2-mediated signaling—TNF—osteoarthritis	0.00124	0.00251	CbGpPWpGaD
Suramin—SIRT1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoarthritis	0.00123	0.00248	CbGpPWpGaD
Suramin—ARSA—Metabolism—BGN—osteoarthritis	0.00122	0.00248	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	0.00122	0.00247	CbGpPWpGaD
Suramin—F2—Vitamin B12 Metabolism—TNF—osteoarthritis	0.00122	0.00247	CbGpPWpGaD
Suramin—PLA2G2A—Spinal Cord Injury—TNF—osteoarthritis	0.00121	0.00245	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—ADAMTS5—osteoarthritis	0.00119	0.0024	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—ADAMTS3—osteoarthritis	0.00119	0.0024	CbGpPWpGaD
Suramin—PLA2G4A—AGE/RAGE pathway—MMP9—osteoarthritis	0.00118	0.00239	CbGpPWpGaD
Suramin—F2—Selenium Micronutrient Network—PTGS2—osteoarthritis	0.00117	0.00236	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—PTGES—osteoarthritis	0.00116	0.00234	CbGpPWpGaD
Suramin—SIRT1—Integrated Pancreatic Cancer Pathway—TNF—osteoarthritis	0.00115	0.00232	CbGpPWpGaD
Suramin—P2RY2—GPCR ligand binding—CXCL8—osteoarthritis	0.00109	0.00221	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—MMP3—osteoarthritis	0.00109	0.00221	CbGpPWpGaD
Suramin—P2RY2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoarthritis	0.00109	0.0022	CbGpPWpGaD
Suramin—F2—Selenium Micronutrient Network—IL1B—osteoarthritis	0.00109	0.0022	CbGpPWpGaD
Suramin—F2—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—osteoarthritis	0.00108	0.00218	CbGpPWpGaD
Suramin—FSHR—GPCR ligand binding—CXCL8—osteoarthritis	0.00106	0.00214	CbGpPWpGaD
Suramin—F2—Regulation of Actin Cytoskeleton—FN1—osteoarthritis	0.00106	0.00213	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—MMP3—osteoarthritis	0.00106	0.00213	CbGpPWpGaD
Suramin—ARSA—Metabolism of proteins—MMP1—osteoarthritis	0.00103	0.00208	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—MCF2L—osteoarthritis	0.00102	0.00205	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—ADAMTS4—osteoarthritis	0.00101	0.00204	CbGpPWpGaD
Suramin—ARSA—Metabolism of proteins—LEP—osteoarthritis	0.000997	0.00202	CbGpPWpGaD
Suramin—F2—Folate Metabolism—TNF—osteoarthritis	0.000993	0.00201	CbGpPWpGaD
Suramin—F2—Vitamin B12 Metabolism—IL6—osteoarthritis	0.000985	0.00199	CbGpPWpGaD
Suramin—PLA2G2A—Spinal Cord Injury—IL6—osteoarthritis	0.000977	0.00198	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—BMP2—osteoarthritis	0.000931	0.00188	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—IHH—osteoarthritis	0.000922	0.00186	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—MCF2L—osteoarthritis	0.000922	0.00186	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—BMP2—osteoarthritis	0.000899	0.00182	CbGpPWpGaD
Suramin—SIRT1—Circadian rythm related genes—IL6—osteoarthritis	0.000888	0.0018	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—MCF2L—osteoarthritis	0.000844	0.0017	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—IHH—osteoarthritis	0.000844	0.0017	CbGpPWpGaD
Suramin—ARSA—Metabolism of proteins—IGF1—osteoarthritis	0.000824	0.00167	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—GSTO1—osteoarthritis	0.000815	0.00165	CbGpPWpGaD
Suramin—F2—Folate Metabolism—IL6—osteoarthritis	0.000801	0.00162	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—ESR1—osteoarthritis	0.000801	0.00162	CbGpPWpGaD
Suramin—ARSA—Metabolism of proteins—MMP2—osteoarthritis	0.000797	0.00161	CbGpPWpGaD
Suramin—ARSA—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	0.000791	0.0016	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—BGN—osteoarthritis	0.000789	0.0016	CbGpPWpGaD
Suramin—F2—Selenium Micronutrient Network—TNF—osteoarthritis	0.000789	0.00159	CbGpPWpGaD
Suramin—F2—Platelet activation, signaling and aggregation—FN1—osteoarthritis	0.00077	0.00156	CbGpPWpGaD
Suramin—F2—Hemostasis—HSPA5—osteoarthritis	0.000734	0.00148	CbGpPWpGaD
Suramin—SIRT1—Cellular responses to stress—IL6—osteoarthritis	0.000714	0.00144	CbGpPWpGaD
Suramin—PLA2G4A—Platelet activation, signaling and aggregation—FN1—osteoarthritis	0.000704	0.00142	CbGpPWpGaD
Suramin—F2—Hemostasis—TIMP1—osteoarthritis	0.0007	0.00141	CbGpPWpGaD
Suramin—SIRT1—Gene Expression—SMAD3—osteoarthritis	0.000694	0.0014	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—IGF1—osteoarthritis	0.000693	0.0014	CbGpPWpGaD
Suramin—F2—Platelet activation, signaling and aggregation—IGF1—osteoarthritis	0.000675	0.00136	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—HSPA5—osteoarthritis	0.000672	0.00136	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—FMOD—osteoarthritis	0.000669	0.00135	CbGpPWpGaD
Suramin—ARSA—Metabolism of proteins—CXCL8—osteoarthritis	0.000663	0.00134	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—MMP3—osteoarthritis	0.000645	0.0013	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—TIMP1—osteoarthritis	0.00064	0.00129	CbGpPWpGaD
Suramin—F2—Selenium Micronutrient Network—IL6—osteoarthritis	0.000637	0.00129	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—MMP3—osteoarthritis	0.000623	0.00126	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—CXCL8—osteoarthritis	0.000618	0.00125	CbGpPWpGaD
Suramin—PLA2G4A—Platelet activation, signaling and aggregation—IGF1—osteoarthritis	0.000617	0.00125	CbGpPWpGaD
Suramin—F2—Peptide ligand-binding receptors—CXCL8—osteoarthritis	0.000612	0.00124	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—CXCL8—osteoarthritis	0.000597	0.00121	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—SMAD3—osteoarthritis	0.000584	0.00118	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—HSPA5—osteoarthritis	0.000578	0.00117	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—PTGS2—osteoarthritis	0.000575	0.00116	CbGpPWpGaD
Suramin—SIRT1—Gene Expression—ESR1—osteoarthritis	0.000566	0.00114	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—SMAD3—osteoarthritis	0.000564	0.00114	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—CXCL8—osteoarthritis	0.000562	0.00114	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—PTGES—osteoarthritis	0.000545	0.0011	CbGpPWpGaD
Suramin—F2—Signaling Pathways—MCF2L—osteoarthritis	0.000545	0.0011	CbGpPWpGaD
Suramin—F2—Signaling Pathways—IHH—osteoarthritis	0.000545	0.0011	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—CXCL8—osteoarthritis	0.000542	0.0011	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	0.00051	0.00103	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—LEP—osteoarthritis	0.000499	0.00101	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—IHH—osteoarthritis	0.000498	0.00101	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—MCF2L—osteoarthritis	0.000498	0.00101	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—LEP—osteoarthritis	0.000482	0.000975	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—ESR1—osteoarthritis	0.000477	0.000963	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—FN1—osteoarthritis	0.000471	0.000952	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—ESR1—osteoarthritis	0.00046	0.00093	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—FN1—osteoarthritis	0.000455	0.000919	CbGpPWpGaD
Suramin—F2—Hemostasis—MMP1—osteoarthritis	0.000435	0.000879	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—TGFB1—osteoarthritis	0.000416	0.00084	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—IGF1—osteoarthritis	0.000413	0.000834	CbGpPWpGaD
Suramin—F2—Class A/1 (Rhodopsin-like receptors)—CXCL8—osteoarthritis	0.000411	0.00083	CbGpPWpGaD
Suramin—F2—Platelet activation, signaling and aggregation—TGFB1—osteoarthritis	0.000404	0.000817	CbGpPWpGaD
Suramin—F2—Signaling Pathways—COL9A2—osteoarthritis	0.0004	0.000808	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—IGF1—osteoarthritis	0.000398	0.000805	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—MMP1—osteoarthritis	0.000398	0.000804	CbGpPWpGaD
Suramin—F2—Hemostasis—FN1—osteoarthritis	0.000397	0.000802	CbGpPWpGaD
Suramin—F2—Signaling Pathways—COL9A1—osteoarthritis	0.000388	0.000785	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—TNF—osteoarthritis	0.000388	0.000785	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—GSTO1—osteoarthritis	0.000384	0.000776	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—BGN—osteoarthritis	0.000372	0.000752	CbGpPWpGaD
Suramin—PLA2G4A—Platelet activation, signaling and aggregation—TGFB1—osteoarthritis	0.00037	0.000748	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—COL9A2—osteoarthritis	0.000366	0.000739	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—FN1—osteoarthritis	0.000363	0.000734	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—COL9A1—osteoarthritis	0.000355	0.000718	CbGpPWpGaD
Suramin—ARSA—Metabolism—PTGS2—osteoarthritis	0.000352	0.000712	CbGpPWpGaD
Suramin—F2—Hemostasis—IGF1—osteoarthritis	0.000348	0.000703	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—MMP1—osteoarthritis	0.000342	0.000691	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—CXCL8—osteoarthritis	0.000332	0.000671	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—LEP—osteoarthritis	0.000331	0.000669	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—CXCL8—osteoarthritis	0.00032	0.000648	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—IGF1—osteoarthritis	0.000318	0.000643	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—IL6—osteoarthritis	0.000315	0.000638	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—CXCL8—osteoarthritis	0.000313	0.000632	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—MMP3—osteoarthritis	0.000312	0.000631	CbGpPWpGaD
Suramin—F2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoarthritis	0.000312	0.00063	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—IL6—osteoarthritis	0.000305	0.000616	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—MMP9—osteoarthritis	0.0003	0.000607	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—MMP9—osteoarthritis	0.00029	0.000586	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—MMP3—osteoarthritis	0.000286	0.000577	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—IGF1—osteoarthritis	0.000274	0.000553	CbGpPWpGaD
Suramin—F2—Signaling Pathways—BMP2—osteoarthritis	0.000266	0.000538	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—MMP2—osteoarthritis	0.000265	0.000535	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—TGFB1—osteoarthritis	0.000247	0.0005	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—BMP2—osteoarthritis	0.000243	0.000492	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	0.00024	0.000485	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—TGFB1—osteoarthritis	0.000239	0.000483	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—PTGS2—osteoarthritis	0.000227	0.000459	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—CXCL8—osteoarthritis	0.00022	0.000445	CbGpPWpGaD
Suramin—F2—Hemostasis—TGFB1—osteoarthritis	0.000208	0.000421	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—TGFB1—osteoarthritis	0.000191	0.000385	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—IL6—osteoarthritis	0.000186	0.000377	CbGpPWpGaD
Suramin—F2—Signaling Pathways—MMP3—osteoarthritis	0.000184	0.000373	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—IL6—osteoarthritis	0.00018	0.000364	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—CXCL8—osteoarthritis	0.000177	0.000357	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—MMP3—osteoarthritis	0.000169	0.000341	CbGpPWpGaD
Suramin—F2—Signaling Pathways—SMAD3—osteoarthritis	0.000167	0.000337	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—CXCL8—osteoarthritis	0.00016	0.000324	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—SMAD3—osteoarthritis	0.000153	0.000309	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—CXCL8—osteoarthritis	0.000147	0.000297	CbGpPWpGaD
Suramin—F2—Signaling Pathways—LEP—osteoarthritis	0.000143	0.000288	CbGpPWpGaD
Suramin—F2—Signaling Pathways—ESR1—osteoarthritis	0.000136	0.000275	CbGpPWpGaD
Suramin—F2—Signaling Pathways—FN1—osteoarthritis	0.000135	0.000272	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—LEP—osteoarthritis	0.00013	0.000264	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—ESR1—osteoarthritis	0.000125	0.000252	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—FN1—osteoarthritis	0.000123	0.000249	CbGpPWpGaD
Suramin—F2—Signaling Pathways—IGF1—osteoarthritis	0.000118	0.000238	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—IGF1—osteoarthritis	0.000108	0.000218	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—PTGS2—osteoarthritis	0.000107	0.000216	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CXCL8—osteoarthritis	9.48e-05	0.000192	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—IL6—osteoarthritis	9.02e-05	0.000182	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CXCL8—osteoarthritis	8.67e-05	0.000175	CbGpPWpGaD
Suramin—F2—Signaling Pathways—MMP9—osteoarthritis	8.58e-05	0.000173	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—IL6—osteoarthritis	8.25e-05	0.000167	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—MMP9—osteoarthritis	7.84e-05	0.000159	CbGpPWpGaD
Suramin—F2—Signaling Pathways—TGFB1—osteoarthritis	7.07e-05	0.000143	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—TGFB1—osteoarthritis	6.46e-05	0.000131	CbGpPWpGaD
Suramin—F2—Signaling Pathways—IL6—osteoarthritis	5.33e-05	0.000108	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—IL6—osteoarthritis	4.87e-05	9.85e-05	CbGpPWpGaD
